Advanced search
Publication Cover
Journal of Medical Economics Volume 23, 2020 - Issue 9
Submit an article Journal homepage
1,379
Views
2
CrossRef citations to date
0
Altmetric
Rheumatology

Comparison of infection-related hospitalization risk and costs in tumor necrosis factor inhibitor-experienced patients with rheumatoid arthritis (RA) treated with abatacept or other targeted disease-modifying anti-rheumatic drugs (tDMARDs)

Damemarie PaulBristol-Myers Squibb, Lawrence Township, NJ, USA
,
Dhaval PatilBristol-Myers Squibb, Lawrence Township, NJ, USA
,
Laura McDonaldBristol-Myers Squibb, Lawrence Township, NJ, USA
,
Vardhaman PatelBristol-Myers Squibb, Lawrence Township, NJ, USACorrespondence[email protected]
&
Francis LoboBristol-Myers Squibb, Lawrence Township, NJ, USA
Pages 1025-1031 | Received 19 Nov 2019, Accepted 29 Apr 2020, Published online: 13 Jun 2020

References

  • Helmick CG, Felson DT, Lawrence RC, et al. Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part I. Arthritis Rheum. 2008;58(1):15–25.
  • Pruijn GJ, Wiik A, van Venrooij WJ. The use of citrullinated peptides and proteins for the diagnosis of rheumatoid arthritis. Arthritis Res Ther. 2010;12(1):203.
  • Brooks PM. The burden of musculoskeletal disease-a global perspective. Clin Rheumatol. 2006;25(6):778–781.
  • Chen C-I, Wang L, Wei W, et al. Burden of rheumatoid arthritis among US Medicare population: co-morbidities, health-care resource utilization and costs. Rheumatology Advances in Practice. 2018;2(1):rky005.
  • Birnbaum H, Pike C, Kaufman R, et al. Societal cost of rheumatoid arthritis patients in the US. Curr Med Res Opin. 2010;26(1):77–90.
  • Singh JA, Saag KG, Bridges SL, Jr, et al. 2015 American college of rheumatology guideline for the treatment of rheumatoid arthritis. Arthritis Rheumatol. 2016;68(1):1–26.
  • Smolen JS, Landewe R, Bijlsma J, et al. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update. Ann Rheum Dis. 2017;76(6):960–977.
  • Stevenson M, Archer R, Tosh J, et al. Adalimumab, etanercept, infliximab, certolizumab pegol, golimumab, tocilizumab and abatacept for the treatment of rheumatoid arthritis not previously treated with disease-modifying antirheumatic drugs and after the failure of conventional disease-modifying antirheumatic drugs only: systematic review and economic evaluation. Health Technol Assess. 2016;20(35):1–610.
  • Jinno S, Lu N, Jafarzadeh SR, et al. Trends in Hospitalizations for Serious Infections in Patients With Rheumatoid Arthritis in the US Between 1993 and 2013. Arthritis Care Res. 2018;70(4):652–658.
  • Smitten AL, Choi HK, Hochberg MC, et al. The risk of hospitalized infection in patients with rheumatoid arthritis. J Rheumatol. 2008;35(3):387–393.
  • Torio C, (AHRQ), Moore B. (Truven Health Analytics). National Inpatient Hospital Costs: The Most Expensive Conditions by Payer. 2013. HCUP Statistical Brief #204. May 2016. Agency for Healthcare Research and Quality, Rockville, MD; [cited 2020 May 21]. Available from: http://www.hcup-us.ahrq.gov/reports/statbriefs/sb204-Most-Expensive-Hospital-Conditions.pdf.
  • Chen SK, Liao KP, Liu J, et al. Risk of Hospitalized Infection and Initiation of Abatacept versus TNF Inhibitors among Patients with Rheumatoid Arthritis: a Propensity Score-Matched Cohort Study. Arthritis Care Res. 2018;72(1):9–17.
  • Yun H, Xie F, Delzell E, et al. Comparative risk of hospitalized infection associated with biologic agents in rheumatoid arthritis patients enrolled in medicare. Arthritis Rheumatol. 2016;68(1):56–66.
  • Truven MarketScan Database. [cited 2017 May 27]. Available from: https://truvenhealth.com/Portals/0/Assets/2017-MarketScan-Databases-Life-Sciences-Researchers-WP.pdf.
  • IQVIA Real-world Data Adjucicated Claims (PharMetrics Plus); [cited 2019 Jun 13]. Available from: https://www.iqvia.com/institute/research-support.
  • U.S. Census Bureau, Population Division. Annual Estimates of the Resident Population for Selected Age Groups by Sex for the United States, States, Counties, and Puerto Rico Commonwealth and Municipios: April 1, 2010 to July 1, 2014.
  • Pawar A, Desai RJ, Solomon DH, et al. Risk of serious infections in tocilizumab versus other biologic drugs in patients with rheumatoid arthritis: a multidatabase cohort study. Ann Rheum Dis. 2019;78(4):456–464.
  • Hunter TM, Boytsov NN, Zhang X, et al. Prevalence of rheumatoid arthritis in the United States adult population in healthcare claims databases, 2004–2014. Rheumatol Int. 2017;37(9):1551–1557.
  • Magellan Rx Management Medical Pharmacy Trend Report. 2018. 9th Edition; [cited 2019 Jun 13]. Available from:https://www1.magellanrx.com/documents/2019/03/medical-pharmacy-trend-report_2018.pdf/.
  • Yun H, Xie F, Delzell E, et al. Risk of hospitalised infection in rheumatoid arthritis patients receiving biologics following a previous infection while on treatment with anti-TNF therapy. Ann Rheum Dis. 2015;74(6):1065–1071.
  • Montastruc F, Renoux C, Hudson M, et al. Abatacept initiation in rheumatoid arthritis and the risk of serious infection: a population-based cohort study. Semin Arthritis Rheu. 2019;48(6):1053–1058.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.